Improvement of Health Status Following Initiation of Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction is a research paper published in JACC Heart Failure (2020). On theSindex it has a DataRank of 1.6. It has been cited 33 times, with 26 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.529
From this paper's citation signal
Citation Network Contribution
1.0
From 21 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 26 citers.
Abbott Laboratories
Bayer Fund
Merck
Bristol-Myers Squibb
Novartis Pharmaceuticals Corporation
Sphingotec GmbH
AstraZeneca
Boehringer Ingelheim
MyoKardia
Cytokinetics
National Institutes of Health
Pfizer
American Heart Association
Amgen
GlaxoSmithKline
Sanofi Pasteur
Daiichi-Sankyo
Medtronic
Novartis
AbbVie
Gilead Sciences
Janssen Pharmaceuticals
National Heart, Lung, and Blood Institute
Roche
MeSH Terms
Keywords